MARKET

CDIOW

CDIOW

Cardio Diagnostics Holdings Inc
NASDAQ
0.0182
0.0000
0.00%
Closed 09:30 07/01 EDT
OPEN
0.0182
PREV CLOSE
0.0182
HIGH
0.0182
LOW
0.0182
VOLUME
893
TURNOVER
0
52 WEEK HIGH
0.0721
52 WEEK LOW
0.0100
MARKET CAP
--
P/E (TTM)
-0.0054
1D
5D
1M
3M
1Y
5Y
1D
Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans
TipRanks · 17h ago
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026
Seeking Alpha · 19h ago
Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks
TipRanks · 1d ago
Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection
TipRanks · 2d ago
Weekly Report: what happened at CDIO last week (0622-0626)?
Weekly Report · 3d ago
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
TipRanks · 06/24 18:00
Cardio Diagnostics announces AHP to cover Epi+Gen CHD, PrecisionCHD
TipRanks · 06/24 12:45
Cardio Diagnostics tests gain coverage at Atlas Healthcare Physicians network from May 2026
PUBT · 06/24 12:35
More
About CDIOW
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Webull offers Cardio Diagnostics Holdings Inc stock information, including NASDAQ: CDIOW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDIOW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDIOW stock methods without spending real money on the virtual paper trading platform.